Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis.

Sathianathen NJ. et al, (2020), Eur Urol

Harnessing the potential of multimodal radiotherapy in prostate cancer.

Philippou Y. et al, (2020), Nat Rev Urol

Implications of celebrity endorsement of prostate cancer awareness in a tertiary referral unit- The "Fry-Turnbull" Effect.

Lovegrove CE. et al, (2020), BJU Int

The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progression.

Bryant RJ. et al, (2020), BJU Int

Re: Pembrolizumab for Treatment-refractory Metastatic Castration-resistant Prostate Cancer: Multicohort, Open-label Phase II KEYNOTE-199 Study

Philippou Y. et al, (2020), European Urology

Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received.

Neal DE. et al, (2019), Eur Urol

VANCE: First-in-human phase I study of a novel ChAdOx1-MVA 5T4 vaccine in low and intermediate risk prostate cancer

(2019), Journal of Clinical Oncology

Comparison of Multiparametric Magnetic Resonance Imaging and Targeted Biopsy With Systematic Biopsy Alone for the Diagnosis of Prostate Cancer: A Systematic Review and Meta-analysis.

Elwenspoek MMC. et al, (2019), JAMA Netw Open, 2

Testicular cancer in men with undescended testis: Insights from the Thames Valley Testicular Cancer database

(2019), Journal of Clinical Urology

Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy.

Wu X. et al, (2019), Prostate, 79, 1079 - 1089

Anti-androgens regulate amino acid-mTORC1 signalling and extracellular vesicle secretion to modulate prostate cancer progression

McCormick K. et al, (2019), CLINICAL & EXPERIMENTAL METASTASIS, 36, 167 - 167

Comparison of Prostate Biopsy with or without Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Detection: An Observational Cohort Study.

Bryant RJ. et al, (2019), J Urol, 201, 510 - 519

An Oncolytic Virus Expressing a T-cell Engager Simultaneously Targets Cancer and Immunosuppressive Stromal Cells.

Freedman JD. et al, (2018), Cancer Res, 78, 6852 - 6865

Does the introduction of prostate multiparametric magnetic resonance imaging into the active surveillance protocol for localized prostate cancer improve patient re-classification?

Bryant RJ. et al, (2018), BJU Int, 122, 794 - 800

Prostatic capsular incision during radical prostatectomy has important oncological implications: a systematic review and meta-analysis.

Philippou Y. et al, (2018), BJU Int

Nuclear IGF1R Interacts with Regulatory Regions of Chromatin to Promote RNA Polymerase II Recruitment and Gene Expression Associated with Advanced Tumor Stage.

Aleksic T. et al, (2018), Cancer Res, 78, 3497 - 3509

First Report of Prostate-specific Membrane Antigen-targeted Immunotherapy in Prostate Cancer: The Future is Bright.

Lamb AD. et al, (2018), Eur Urol, 73, 653 - 655

Patched 1 Expression Correlates with Biochemical Relapse in High-Risk Prostate Cancer Patients.

Gonnissen A. et al, (2018), Am J Pathol, 188, 795 - 804

The management of non-muscle-invasive bladder cancer: A comparison of European and UK guidelines

Leiblich A. et al, (2018), Journal of Clinical Urology, 11, 144 - 148

Diagnostic Pathways for Screen-detected Prostate Cancer: The Plot Thickens.

Hamdy FC. et al, (2017), Eur Urol

Load More

Include forthcoming?